PATRICIA I DELGADO MD NPI 1003888165

NPI Information

  • NPI: 1003888165
  • Provider Name: PATRICIA I DELGADO, MD
  • Classification: Pathology - 207ZP0105X
  • Specialization: Clinical Pathology/Laboratory Medicine
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4665 PONCE DE LEON BLVD
    CORAL GABLES, FL
    ZIP 33146
  • Phone: (786) 464-0749

Map and Directions

Get Directions

NPI Details

Patricia I Delgado, MD is a clinical pathology/laboratory medicine pathology in Coral Gables, FL with 31 years of experience. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. Patricia I Delgado, MD NPI is 1003888165. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Graduation Year:1994

The provider's business location address is:

4665 PONCE DE LEON BLVD
CORAL GABLES, FL
ZIP 33146-101
Phone: (786) 464-0749
Fax: (786) 953-5764

The NPI 1003888165 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
  • Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
  • Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Pap test (HCPCS:88141)
  • Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
  • Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
  • Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
  • Microscopic genetic analysis of tumor, manual (HCPCS:88360)
  • Measurement of rna of bacteria in vaginal fluid specimen (HCPCS:81513)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
  • Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)

The enumeration date for this NPI number is 2/3/2006 and was last updated on 11/20/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207ZP0105XPathologyClinical Pathology/Laboratory MedicineME74394FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.